RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia (Q45054546)

9 December 2017

RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia (English)

1 reference

9 December 2017

1 reference

2

Ayalew Tefferi

1 reference

9 December 2017

Letetia C Jones

1

1 reference

9 December 2017

Gregory E Idos

3

1 reference

9 December 2017

Takashi Kumagai

4

1 reference

9 December 2017

Wolf-K Hofmann

5

1 reference

9 December 2017

H Phillip Koeffler

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

23

1 reference

9 December 2017

47

1 reference

9 December 2017

7846-7853

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207510

9 December 2017

0 references

cites work

Retinoic acid receptor fusion proteins: friend or foe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Tumor suppressors on 3p: a neoclassic quartet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Function of RARalpha during the maturation of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Comparative genomic analysis of tumors: detection of DNA losses and amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

RAR beta 2-mediated growth inhibition in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

21 January 2018

VHL: a very hip ligase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Lineage restriction of the RARalpha gene expression in myeloid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

RARbeta involvement in enhancement of lung tumor cell immunogenicity revealed by array analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

Allelotype analysis of the myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207510

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207510

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference